PFE 8-K 2026-08-04
PFIZER INC (PFE) 8-K dated 2026-08-04 — accession 0000078003-26-000094. This URL is the filing, not the PFE hub.
PFIZER INC (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla D.V.M., Ph.D..
PFE to acquire platform ($1.5B)
Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B.
Not investment advice. The PFE SEC hub lists recent forms. The stock page is the research view.
- Diluted EPS
- $0.77
- Guidance
- full-year 2026 Revenue guidance by $500 million at the midpoint while reaffirming guidance (2) for Adjusted (3) diluted EPS, whic
- Deal
- $1.5B
Why it matters
- full-year 2026 Revenue guidance by $500 million at the midpoint while reaffirming guidance (2) for Adjusted (3) diluted EPS, whic
- Transaction value about $1.5B